Chargement en cours...
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...
Enregistré dans:
| Publié dans: | Mol Med Rep |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/ https://ncbi.nlm.nih.gov/pubmed/26059981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|